Idexx Laboratories has grown revenue 9.0% a year over three years and 8.4% a year over five, with earnings per share compounding at 15%. Revenue growth, 3-year annual rate: +9.0% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +8.4%, growth has picked up over the last three years. Earnings per share, 3-year rate: +15%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 18, FY2008 to FY2025, as filed.

IDXXIdexx Laboratories

HealthcareUSD

$553.16

$528.6852 weeks$766.68

Is it growing?

Is IDXX growing?

Idexx Laboratories has grown revenue 9.0% a year over three years and 8.4% a year over five, with earnings per share compounding at 15%.

+9.0%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +8.4%
Revenue growth, 5-year rate · +9.0% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +15%
Earnings per share, 3-year rate · revenue +9.0% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed